American Healthcare Capital Exclusively Advises Clinical Specialty Infusions (CSI) Pharmacy in Their Merger With a Market Leader in Home Health, Palliative Care, and Hospice

American Healthcare Capital, a national healthcare M&A advisory firm, is pleased to announce the merger of CSI Pharmacy and a market leader in Home Health, Palliative Care, and Hospice.

Jan. 14, 2020 22:08 UTC

LOS ANGELES--(BUSINESS WIRE)-- American Healthcare Capital (www.americanhealthcarecapital.com), a national healthcare M&A advisory firm, is pleased to announce the merger of CSI Pharmacy (https://www.csipharmacy.com/) and a market leader in Home Health, Palliative Care, and Hospice. With over $30 million in annualized revenue, CSI Pharmacy is a multi-state specialty infusion pharmacy dedicated to servicing patients with chronic and rare illnesses. Since 2013, CSI has grown from a single retail location to serving thousands of infusion patients in over 30 states. Functioning as a support to this deal was Miller & Vess P.C. (http://legalcpa.com/) and Waller Law (www.wallerlaw.com).

“This was an extremely rewarding process as it met our client’s full criteria. My team and I look forward to remaining involved with both organizations and seeing their progress for years to come,” stated Andre Ulloa, lead advisor and Vice President of Team M+A at American Healthcare Capital.

James Sheets, Owner and CEO of CSI Pharmacy, added, “It is not possible to overstate the value that Andre Ulloa brought to our business. From the very beginning he not only exceeded our service expectations, but completely ‘blew them out of the water’! We couldn’t be more pleased with this transaction. Our senior management team now has a partner with resources and expertise to meet our growth initiatives, while maintaining our commitment to exceptional care.”

Since 1990, American Healthcare Capital has been one of the nation’s largest and most successful M&A advisory firms. Team M+A (www.HealthcareDealTeam.com) at American Healthcare Capital consists of the company’s top performing advisors and analysts: Mike Moran, Andre Ulloa, and Mark Thomas. The merger of CSI marks the 15th successful closing for Team M+A in 2019 which includes transactions in Home Health, Medicaid Home Care, Private Duty, all types of Pharmacy, Hospice, Behavioral Health, Long Term Care Facilities, Physical Therapy, and DME.

For any questions regarding Team M+A, selling your healthcare business, or targeting a healthcare acquisition, please contact Mark Thomas at mark@ahcteam.com or (310) 693-6697.

About American Healthcare Capital

American Healthcare Capital is a 30-year-old, full service, nationwide Mergers & Acquisitions advisory firm headquartered in Marina Del Rey, California. With over $1 billion in active sell-side and buy-side engagements, they engage with the entire spectrum of the healthcare industry, including but not limited to Home Health, Hospice, Private Duty, Behavioral Health, I/DD, DME, Medical Staffing, Long Term Care, Physical Therapy, Urgent Care and all types of Pharmacy.

American Healthcare Capital’s full scope of services include: sell-side engagements, buy-side engagements, term loans & accounts receivable lending, real estate loans for healthcare facilities, mezzanine financing, SBA loans, valuations & court approved appraisal services.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200114005859/en/

Contacts

Andre Ulloa
Vice President of M&A
American Healthcare Capital
O: (310) 775-2992
M: (323) 633-7335
www.HealthcareDealTeam.com
LinkedIN

Source: American Healthcare Capital

MORE ON THIS TOPIC